NUIX LIMITED (NXL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NXL

NXL - NUIX LIMITED

FNArena Sector : Software & Services
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: 0.51
Index: ALL-ORDS | ALL-TECH

Nuix is an Australian technology company providing investigative analytics and intelligence software for transforming large amounts of data into actionable intelligence. The company listed in December 2020.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.04

27 Aug
2026

-0.090

OPEN

$2.10

-4.23%

HIGH

$2.10

6,589,087

LOW

$1.98

TARGET
$3.00 47.1% upside
OTHER COMPANIES IN THE SAME SECTOR
360 . ALC . AMX . AR9 . ATA . AV1 . BMT . COS . DOC . EIQ . GTK . KYP . PPL . RDY . SKO . UBN . VGL . XF1 . YOJ .
FNARENA'S MARKET CONSENSUS FORECASTS
NXL: 1
Title FY25
Actual		 FY26
Actual		 FY27
Forecast		 FY28
Forecast
EPS (cps) xxx 4.9 8.6 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A 75.2% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 24.3 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx4.9
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx263.2 M
Book Value Per Share xxxxxxxxxxxxxxx92.4
Net Operating Cash Flow xxxxxxxxxxxxxxx60.7 M
Net Profit Margin xxxxxxxxxxxxxxx6.25 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx5.45 %
Return on Invested Capital xxxxxxxxxxxxxxx5.10 %
Return on Assets xxxxxxxxxxxxxxx3.34 %
Return on Equity xxxxxxxxxxxxxxx5.45 %
Return on Total Capital xxxxxxxxxxxxxxx9.59 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx58.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx38 M
Total Debt xxxxxxxxxxxxxxx41 M
Goodwill - Gross xxxxxxxxxxxxxxx42 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx70 M
Price To Book Value xxxxxxxxxxxxxxx1.31

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx23.4 M
Capex % of Sales xxxxxxxxxxxxxxx8.89 %
Cost of Goods Sold xxxxxxxxxxxxxxx76 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx156 M
Research & Development xxxxxxxxxxxxxxx36 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

26/08/2026

1

Overweight

$3.00

47.06%

Nuix's FY26 result was well ahead of Morgan Stanley's expectations, with underlying EBITDA beating the broker's forecast by 18%, while ACV reached $260m, up 14% y/y versus 12% expected.

The standout was Nuix Neo, with ACV surging 179% to $79m and the platform now accounting for 30% of group ACV. The analyst believes Nuix is emerging as an AI winner.

Neo's strong customer uptake is accelerating new customer wins and increased spending from existing customers, supporting stronger revenue and earnings growth.

FY27 guidance is for ACV growth of 10%-15% to $285m-$300m, despite Nuix stepping up product R&D investment by around 25%. FY27-FY29 EBITDA forecasts rise by 6%-10% and EPS forecasts by 9%-27%, respectively.

Overweight retained along with a higher target of $3 from $2.50 target. Industry View: Attractive.

FORECAST
Morgan Stanley forecasts a full year FY27 dividend of 0.00 cents and EPS of 8.60 cents.
Morgan Stanley forecasts a full year FY28 dividend of 0.00 cents and EPS of 9.70 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Moelis

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Shaw and Partners

06/02/2026

0

Cessation of coverage

Shaw and Partners ceased coverage of Nuix due to a reallocation of resources.
Access Extra Coverage Research History >

NXL STOCK CHART

FNArena News on NXL

1
In Brief: Nuix, Abacus Group & NetWealth Group

Aug 28 2026 - Weekly Reports
2
FNArena Corporate Results Monitor – 26-08-2026

Aug 26 2026 - Australia
3
Australian Broker Call *Extra* Edition – Aug 26, 2026

Aug 26 2026 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Aug 17, 2026

Aug 17 2026 - Daily Market Reports
5
Rudi’s View: Final Preparations For August

Aug 05 2026 - Rudi's View

Latest Software & Services News

1
Treasure Chest: WiseTech Global

Jul 09 2026 - Treasure Chest
2
Software In The ‘Age Of Intelligence’

Jun 01 2026 - International
3
TechnologyOne’s AI Advantage

May 29 2026 - Australia
4
Gentrack Growth Story Under Scrutiny

May 25 2026 - Small Caps
5
AI Anxiety Continues Post Xero’s Strong Result

May 20 2026 - Australia
6
Latitude Contracts Transform Megaport’s Outlook

May 19 2026 - Small Caps
7
Plenty Of Questions Surround Life360’s Outlook

May 18 2026 - Australia
8
Market Concerns Eclipse NextDC’s Growth Outlook

Mar 13 2026 - Australia
9
WiseTech Juggling AI Risks And Growth Levers

Mar 11 2026 - Australia
10
Life360, Growth Deferred Or Denied?

Mar 05 2026 - Australia